YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia, and guest Houda…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Houda Hachad, Vice President of Clinical Operations…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia®, and Houda…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia®, and Houda…
Read More
Aranscia® solutions help oncologists comply with new FDA warning label requiring DPYD genetic testing in patients receiving select chemotherapies HOUSTON, Oct. 16, 2025 /PRNewswire/ -- Oncologists and pharmacy experts are reacting to last…
Read More
Polypharmacy, adverse drug events, the Beers Criteria, and pain management. “Personalized prescribing in long-term care: Why it matters more than ever,” by Joel Diamond, CMO of YouScript's Partner, AccessDx Laboratory, in McKnight’s…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Watch the latest here: https://vimeo.com/1097669214/87a0886a15?ts=7560&share=copy Host Kristine Ashcraft,…
Read More
Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is…
Read More
